Company Filing History:
Years Active: 2012-2021
Title: Eui-Cheol Jo: Innovator in Biotechnology
Introduction
Eui-Cheol Jo is a prominent inventor based in Yongin-si, South Korea. He has made significant contributions to the field of biotechnology, holding a total of eight patents. His work focuses on developing innovative therapeutic agents, particularly for hemophilia and gene therapy.
Latest Patents
Among his latest patents is a chimera protein comprising FVIII and vWF factors. This chimera protein has a significantly increased in vivo half-life when administered, enhancing patient convenience and reducing medical expenses for hemophilia A treatment. Another notable patent involves a hexon isolated from simian adenovirus serotype 19. This invention addresses safety and effective systemic treatment for developing gene therapeutic agents using adenovirus.
Career Highlights
Eui-Cheol Jo has worked with reputable organizations, including Mogam Biotechnology Research Institute and The Green Cross Corporation. His experience in these institutions has allowed him to advance his research and contribute to significant innovations in biotechnology.
Collaborations
He has collaborated with notable colleagues, including Daekyung Koh and Seongtae Yun, to further enhance his research and development efforts.
Conclusion
Eui-Cheol Jo's innovative work in biotechnology, particularly in developing therapeutic agents, showcases his commitment to improving patient care and advancing medical science. His contributions continue to have a lasting impact on the field.
Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.